Treace Medical Stock Target Price and Analyst Consensus
| TMCI Stock | USD 8.52 0.04 0.47% |
The current analyst and expert consensus on Treace Medical is Hold with 6 hold recommendations. The current projected Treace Medical target price consensus is 22.83 with 6 analyst opinions. One of the most common ways Treace Medical Concepts analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Treace Medical vendors, executives, and/or customers. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Treace Medical. We strongly encourage you to use your own analysis of Treace Medical Concepts to validate this buy or sell advice. Treace Medical recommendation module provides expert sentiment on the projected Treace Medical Concepts target price to derive its highest and lowest estimates based on target price standard deviation of 5.5078.
Lowest Forecast 20.78 | Highest Forecast 25.34 | Target Price 22.83 |
Treace |
It's important to approach Treace Medical's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Treace Medical price targets
Treace Medical's stock target price is an estimate of its future price, usually made by analysts. Using Treace Medical's target price to determine if it is a suitable investment can be done through the following steps:- Look at Treace Medical's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Treace Medical's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Treace Medical Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Treace Medical is a key component of Treace Medical valuation and have some predictive power on the future returns of a Treace Medical.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Treace Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Business Services Invested few shares | |
 | Driverless Cars Invested few shares | |
 | Investor Favorites Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Momentum Invested over 200 shares | |
 | FinTech Invested over 40 shares | |
 | Disruptive Technologies Invested few shares | |
 | Cash Cows Invested few shares |
Check out Macroaxis Advice on Treace Medical to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.